Cost effectiveness of MF59 adjuvanted influenza vaccine in France

被引：0
|
作者：
Chambers, J.
Eijgelshoven, I
Piercy, J.
Wait, S.
机构：
[1] Mapi Values, Boston, MA USA
[2] Mapi Values, Houten, Netherlands
[3] Phimap, Bollington, England
[4] SHW Hlth, London, England
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)69036-5
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A163 / A164
页数：2
相关论文
共 50 条
  • [31] Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France
    Paccalin, Marc
    Gavazzi, Gaetan
    Berkovitch, Quentin
    Leleu, Henri
    Moreau, Romain
    Ciglia, Emanuele
    Burlet, Nansa
    Mould-Quevedo, Joaquin F.
    VACCINES, 2024, 12 (06)
  • [32] Safety and effectiveness of MF-59 adjuvanted influenza vaccines in children and adults
    Black, Steven
    VACCINE, 2015, 33 : B3 - B5
  • [33] MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice
    Higgins, DA
    Carlson, JR
    VanNest, G
    VACCINE, 1996, 14 (06) : 478 - 484
  • [34] Immunogenicity and protective efficacy in dogs of an MF59™-adjuvanted vaccine against recombinant canine/porcine coronavirus
    Decaro, Nicola
    Mari, Viviana
    Sciarretta, Rossana
    Colao, Valeriana
    Losurdo, Michele
    Catella, Cristiana
    Elia, Gabriella
    Martella, Vito
    Del Giudice, Giuseppe
    Buonavoglia, Canio
    VACCINE, 2011, 29 (11) : 2018 - 2023
  • [35] The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice
    Cataldo, DM
    VanNest, G
    VACCINE, 1997, 15 (16) : 1710 - 1715
  • [36] MF59™ as a vaccine adjuvant: a review of safety and immunogenicity
    El Sahly, Hana
    EXPERT REVIEW OF VACCINES, 2010, 9 (10) : 1135 - 1141
  • [37] Randomized Trial of a MF-59 Adjuvanted Influenza Vaccine in Kidney Transplant Recipients
    Kumar, D.
    Campbell, P.
    Hidalgo, L.
    Hoschler, K.
    Al-Dabbagh, M.
    Humar, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 767 - 768
  • [38] Randomized Trial of a MF-59 Adjuvanted Influenza Vaccine in Kidney Transplant Recipients
    Kumar, D.
    Campbell, P.
    Hidalgo, L.
    Hoschler, K.
    Al-Dabbagh, M.
    Humar, A.
    TRANSPLANTATION, 2014, 98 : 767 - 768
  • [39] The Cost-Effectiveness of Vaccination of Older Adults with an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Other Available Quadrivalent Vaccines in Germany
    Kohli, Michele A.
    Maschio, Michael
    Cartier, Shannon
    Mould-Quevedo, Joaquin
    Fricke, Frank-Ulrich
    VACCINES, 2022, 10 (09)
  • [40] Immunogenicity and safety of MF59-adjuvanted quadrivalent influenza vaccine versus standard and alternate B strain MF59-adjuvanted trivalent influenza vaccines in older adults
    Essink, Brandon
    Fierro, Carlos
    Rosen, Jeffrey
    Figueroa, Amparo L.
    Zhang, Bin
    Verhoeven, Carole
    Edelman, Jonathan
    Smolenov, Igor
    VACCINE, 2020, 38 (02) : 242 - 250
12345